vimarsana.com
Home
Live Updates
Currently Enrolling Trial Examines Innovative Approach in Inflammatory Breast Cancer : vimarsana.com
Currently Enrolling Trial Examines Innovative Approach in Inflammatory Breast Cancer
The S1706 study is currently enrolling patients with inflammatory breast cancer to determine if adding a PARP inhibitor to radiation therapy is effective.
Related Keywords
France ,
Georgia ,
United States ,
Atlanta ,
Emory University ,
French ,
Reshma Jagsi ,
Lawrencew Davis ,
Translational Breast Cancer Research Consortium ,
Radiation Oncology ,
Emory University School ,
Translational Breast Cancer Research ,
Inflammatory Breast Cancer ,
Radiosensitizing Medication ,
Parp Inhibitor Plus Radiation Therapy ,
Nct03598257 ,
Study S1706 ,
Swog 1706 Study ,
D ,
Phil ,
Radioparp ,
Study Tbcrc 024 Nct01477489 ,
Veliparib ,
Abt 888 ,
Olaparib ,
Lynparza ,
Local Regional Recurrence ,
Radiotherapy ,
vimarsana.com © 2020. All Rights Reserved.